111 related articles for article (PubMed ID: 15924879)
1. Regulatory role of CCAAT/enhancer binding protein-beta in the production of plasma proteins in yolk sac tumor.
Hirashiki K; Kishimoto T; Ishiguro H; Nagai Y; Furuya M; Sekiya S; Ishikura H
Exp Mol Pathol; 2005 Jun; 78(3):247-56. PubMed ID: 15924879
[TBL] [Abstract][Full Text] [Related]
2. Expression of liver-enriched nuclear factors and their isoforms in alpha-fetoprotein-producing gastric carcinoma cells.
Supriatna Y; Kishimoto T; Furuya M; Tochigi N; Ishiguro H; Tosh D; Ishikura H
Exp Mol Pathol; 2007 Jun; 82(3):316-21. PubMed ID: 16904665
[TBL] [Abstract][Full Text] [Related]
3. Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.
Gómez-Santos C; Barrachina M; Giménez-Xavier P; Dalfó E; Ferrer I; Ambrosio S
Brain Res Bull; 2005 Feb; 65(1):87-95. PubMed ID: 15680548
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
Yokota T; Bui T; Liu Y; Yi M; Hunt KK; Keyomarsi K
Cancer Res; 2007 Dec; 67(23):11272-83. PubMed ID: 18056453
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
[TBL] [Abstract][Full Text] [Related]
6. Novel human alpha-fetoprotein mRNA isoform lacking exon 1 identified in ovarian yolk sac tumor.
Fukasawa H; Iwamoto H; Hirata S; Shoda T; Yokota S; Nishi S; Hoshi K
J Soc Gynecol Investig; 2005 Sep; 12(6):456-62. PubMed ID: 15914041
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated expression of the CCAAT/enhancer binding protein alpha and beta genes in human hepatocellular carcinoma: a possible prognostic marker.
Tomizawa M; Watanabe K; Saisho H; Nakagawara A; Tagawa M
Anticancer Res; 2003; 23(1A):351-4. PubMed ID: 12680236
[TBL] [Abstract][Full Text] [Related]
8. Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3 alpha in models of early endodermal cell differentiation.
Roach S; Schmid W; Pera MF
Exp Cell Res; 1994 Nov; 215(1):189-98. PubMed ID: 7957668
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
Seifeddine R; Dreiem A; Blanc E; Fulchignoni-Lataud MC; Le Frère Belda MA; Lecuru F; Mayi TH; Mazure N; Favaudon V; Massaad C; Barouki R; Massaad-Massade L
Cancer Res; 2008 Apr; 68(7):2158-65. PubMed ID: 18381421
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
11. C/EBP alpha and beta mimic retinoic acid activation of IGFBP-5 in neuroblastoma cells by a mechanism independent from binding to their site.
Cesi V; Giuffrida ML; Vitali R; Tanno B; Mancini C; Calabretta B; Raschellà G
Exp Cell Res; 2005 Apr; 305(1):179-89. PubMed ID: 15777798
[TBL] [Abstract][Full Text] [Related]
12. Morphological changes induced by extracellular matrix are correlated with maturation of rat small hepatocytes.
Sugimoto S; Mitaka T; Ikeda S; Harada K; Ikai I; Yamaoka Y; Mochizuki Y
J Cell Biochem; 2002; 87(1):16-28. PubMed ID: 12210718
[TBL] [Abstract][Full Text] [Related]
13. Increased activation of CCAAT/enhancer binding protein-beta correlates with the invasiveness of renal cell carcinoma.
Oya M; Horiguchi A; Mizuno R; Marumo K; Murai M
Clin Cancer Res; 2003 Mar; 9(3):1021-7. PubMed ID: 12631601
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 beta induction of matrix metalloproteinase-1 transcription in chondrocytes requires ERK-dependent activation of CCAAT enhancer-binding protein-beta.
Raymond L; Eck S; Mollmark J; Hays E; Tomek I; Kantor S; Elliott S; Vincenti M
J Cell Physiol; 2006 Jun; 207(3):683-8. PubMed ID: 16453302
[TBL] [Abstract][Full Text] [Related]
15. All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBPbeta and C/EBPepsilon to the BPI promoter.
Lennartsson A; Vidovic K; Pass MB; Cowland JB; Gullberg U
J Leukoc Biol; 2006 Jul; 80(1):196-203. PubMed ID: 16684888
[TBL] [Abstract][Full Text] [Related]
16. CCAAT/enhancer binding protein-beta (C/EBP-beta), a pivotal regulator of the TATA-less promoter in the rat catalase gene.
Taniguchi M; Hashimoto M; Hori N; Sato K
FEBS Lett; 2005 Oct; 579(25):5785-90. PubMed ID: 16223488
[TBL] [Abstract][Full Text] [Related]
17. CCAAT/enhancer binding protein-beta promotes the survival of intravascular rat pancreatic tumor cells via antiapoptotic effects.
Shimizu Y; Kishimoto T; Ohtsuka M; Kimura F; Shimizu H; Yoshidome H; Miyazaki M
Cancer Sci; 2007 Nov; 98(11):1706-13. PubMed ID: 17727681
[TBL] [Abstract][Full Text] [Related]
18. Reciprocal expression of CCAAT/enhancer binding proteins alpha and beta in hepatoblastomas and its prognostic significance.
Tomizawa M; Horie H; Yamamoto H; Matsunaga T; Sasaki F; Hashizume K; Hiyama E; Kaneko M; Suita S; Ando H; Hayashi Y; Ohnuma N; Nakagawara A
Oncol Rep; 2007 Feb; 17(2):341-4. PubMed ID: 17203171
[TBL] [Abstract][Full Text] [Related]
19. Cell- and stage-specific chromatin structure across the Complement receptor 2 (CR2/CD21) promoter coincide with CBF1 and C/EBP-beta binding in B cells.
Cruickshank MN; Fenwick E; Karimi M; Abraham LJ; Ulgiati D
Mol Immunol; 2009 Aug; 46(13):2613-22. PubMed ID: 19487031
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
